PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 15, 2012European Heart Journal75 citationsOpen Access

Epicardial substrate mapping for ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy: a new algorithm to differentiate between scar and viable myocardium developed by simultaneous integration of computed tomography and contrast-enhanced magnetic resonance imaging

View Full Paper
SPSebastiaan R.D. PiersCTCarine F.B. van Huls van TaxisQTQian Tao

Key Result

A newly developed algorithm combining unipolar voltage and electrogram characteristics correctly identified epicardial scar with a sensitivity of 75% in patients with non-ischaemic cardiomyopathy.

Study Design

Type

Observational (n=10)

Structured PICO

Can unipolar voltage, bipolar voltage, and electrogram characteristics distinguish fibrosis from viable myocardium and fat during epicardial EAM for VT ablation in patients with non-ischaemic cardiomyopathy?

P
Population
10 patients with non-ischaemic cardiomyopathy (NICM) and ventricular tachycardia (VT), mean age 56 ± 13 years, 7 males.
I
Intervention
Epicardial electroanatomical mapping (EAM) evaluating unipolar voltage (UV), bipolar voltage (BV), and electrogram characteristics (EC) with real-time integration of CT-derived epicardial fat and contrast-enhanced MRI-derived scar.
O
Outcome
Ability of UV, BV, and EC to distinguish fibrosis from viable myocardium and fat.surrogate

A novel algorithm combining unipolar voltage and electrogram characteristics can differentiate between scar and viable myocardium during epicardial mapping, overcoming the confounding effect of epicardial fat.

Main Result

p-value: p=<0.001

Abstract

AIMS: During epicardial electroanatomical mapping (EAM), it is difficult to differentiate between fibrosis and fat, as both exhibit attenuated bipolar voltage (BV). The purpose of this study was to assess whether unipolar voltage (UV), BV, and electrogram characteristics (EC) can distinguish fibrosis from viable myocardium and fat during epicardial EAM for ventricular tachycardia (VT) ablation in non-ischaemic cardiomyopathy (NICM). METHODS AND RESULTS: Ten NICM patients (7 males, 56 ± 13 years) with VT underwent epicardial EAM with real-time integration of computed tomography-derived epicardial fat and contrast-enhanced MRI-derived scar. Bipolar voltage (filtered 30-400 Hz), UV (filtered 1-240 Hz), and EC (duration and morphology) were correlated with the presence of fat and scar. At sites devoid of fat, the optimal cutoff values to differentiate between scar and myocardium were 1.81 mV for BV and 7.95 mV for UV. Bipolar voltage, UV, and electrogram duration >50 ms distinguished scar from myocardium in areas covered with <2.8 mm fat (all P < 0.001), but not ≥ 2.8 mm fat. In contrast, electrogram morphology-characteristics could also detect scar covered with ≥ 2.8 mm fat (P = 0.001). A newly developed three-step algorithm combining electrogram morphology, duration, and UV could correctly identify scar with a sensitivity of 75%. Unipolar voltage but not BV could detect intramural scar in the absence of fat. CONCLUSIONS: Both BV ≤ 1.81 mV and UV ≤ 7.95 mV are useful for detection of scar during epicardial EAM, in the absence of ≥ 2.8 mm fat. However, EC can be used to detect scar covered with fat. A newly developed algorithm combining UV and EC can differentiate between scar and viable myocardium. Unipolar voltage but not BV could detect intramural scar.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Piers et al. (2012) conducted an observational in Ventricular tachycardia in non-ischaemic cardiomyopathy (n=10). Epicardial electroanatomical mapping with unipolar voltage, bipolar voltage, and electrogram characteristics was evaluated on Optimal cutoff values to differentiate between scar and myocardium at sites devoid of fat (p=<0.001). A newly developed algorithm combining unipolar voltage and electrogram characteristics correctly identified epicardial scar with a sensitivity of 75% in patients with non-ischaemic cardiomyopathy.

synapsesocial.com/papers/6a0eef5b25c30b2cc7f9f175https://doi.org/10.1093/eurheartj/ehs382
Ask AI
Helpful
Bookmark
Share
View Full Paper